Seroatlas · Human Serome Atlas

AKR1C3

Aldo-keto reductase family 1 member C3

Also known as: AK1C3_HUMAN, DDX, HAKRB, HSD17B5, KIAA0119, PGFS

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P42330
Gene
AKR1C3
Ensembl
ENSG00000196139
Chromosome
10
Canonical length
323 aa
Protein class
Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol

OverviewNCBI Gene

This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols by utilizing NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ), and the oxidation of 9alpha,11beta-PGF2 to PGD2. It may play an important role in the pathogenesis of allergic diseases such as asthma, and may also have a role in controlling cell growth and/or differentiation. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]

Canonical amino-acid sequenceUniProt

323 residues, UniProt reviewed canonical sequence.

>P42330|AKR1C3
     1  MDSKHQCVKL NDGHFMPVLG FGTYAPPEVP RSKALEVTKL AIEAGFRHID SAHLYNNEEQ
    61  VGLAIRSKIA DGSVKREDIF YTSKLWSTFH RPELVRPALE NSLKKAQLDY VDLYLIHSPM
   121  SLKPGEELSP TDENGKVIFD IVDLCTTWEA MEKCKDAGLA KSIGVSNFNR RQLEMILNKP
   181  GLKYKPVCNQ VECHPYFNRS KLLDFCKSKD IVLVAYSALG SQRDKRWVDP NSPVLLEDPV
   241  LCALAKKHKR TPALIALRYQ LQRGVVVLAK SYNEQRIRQN VQVFEFQLTA EDMKAIDGLD
   301  RNLHYFNSDS FASHPNYPYS DEY

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against AKR1C3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.22
Highest tissue expression
415 nTPM

Expression across tissuesHPA

Tissue

  • duodenum: 415 nTPM
  • liver: 285 nTPM
  • small intestine: 255 nTPM
  • gallbladder: 246 nTPM
  • stomach: 224 nTPM
  • colon: 190 nTPM

Single-cell type

  • enterocytes: 515 nCPM
  • foveolar cells: 432 nCPM
  • hepatocytes: 414 nCPM
  • urothelial cells: 389 nCPM
  • cholangiocytes: 291 nCPM
  • enteric transient amplifying cells: 266 nCPM

Immune cell

  • basophil: 245 nTPM
  • gdT-cell: 103 nTPM
  • total PBMC: 42 nTPM
  • plasmacytoid DC: 40 nTPM
  • T-reg: 22 nTPM
  • NK-cell: 21 nTPM

Brain region

  • hypothalamus: 21 nTPM
  • basal ganglia: 18 nTPM
  • midbrain: 18 nTPM
  • medulla oblongata: 14 nTPM
  • cerebellum: 13 nTPM
  • pons: 13 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about AKR1C3.

Disease | ImmuneIEDB

Conditions an epitope on AKR1C3 was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.86
gnomAD pLI
0
gnomAD missense Z
-1.81
DepMap mean gene effect
0.02
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of AKR1C3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads AKR1C3 as an antibody target. Whether an autoantibody or antibody against AKR1C3 could matter depends on whether native AKR1C3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

AKR1C3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label AKR1C3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/AKR1C3. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...